High Quality cagrilintide weight loss Raw peptide 1g in Stock
TDS 5 Inquiries
446036-97-1
Pharmaceutical Grade
99.9%
shanghai
SY
10vials/box
2030-02-23
Peptides,steriods oil,pharmaceutical intermediates,chemical,raw powder,Retatrutide
-
Product Description
-
Seller Information
-
Inquiry History
-
DescriptionCertificatesBasic Info
-
Product Name:
CJC -1295 whitout DAC
Other Name:L-Argininamide, L-tyrosyl-D-alanyl-L-α-aspartyl-L-alanyl-L-isoleucyl-L-phenylalanyl-L-threonyl-L-glutaminyl-L-seryl-L-tyrosyl-L-arginyl-L-lysyl-L-valyl-L-leucyl-L-alanyl-L-glutaminyl-L-leucyl-L-seryl-L-alanyl-L-arginyl-L-lysyl-L-leucyl-L-leucyl-L-glutaminyl-L-α-aspartyl-L-isoleucyl-L-leucyl-L-seryl-;L-tyrosyl-D-alanyl-L-α-aspartyl-L-alanyl-L-isoleucyl-L-phenylalanyl-L-threonyl-L-glutaminyl-L-seryl-L-tyrosyl-L-arginyl-L-lysyl-L-valyl-L-leucyl-L-alanyl-L-glutaminyl-L-leucyl-L-seryl-L-alanyl-L-arginyl-L-lysyl-L-leucyl-L-leucyl-L-glutaminyl-L-α-aspartyl-L-isoleucyl-L-leucyl-L-seryl-L-argininamide;CJC -1295 whitout DAC;CIC-1295 With DAC
CAS No.:446036-97-1
Molecular Formula:C152H252N44O42
Molecular Weight:3367.9
Categories:
Characteristics-
Density:
1.43±0.1 g/cm3(Predicted)
Critical Temperature & Pressure:Store at -20°C
Research-
Class:
Amylin receptor (AMYR) / calcitonin receptor (CTR) agonist (long-acting amylin analog)
Status:Investigational — Phase 3 (REDEFINE program, CagriSema combination)
Mechanism:A novel long-acting, acylated amylin (islet amyloid polypeptide, IAPP) analog consisting of 38 amino acids. Cagrilintide activates the amylin receptor (AMYR) and calcitonin receptor (CTR), reducing food intake, delaying gastric emptying, and promoting satiety. Being developed as monotherapy and in fixed-dose combination with semaglutide (CagriSema) for obesity. Administered once weekly.
Activity note:Cagrilintide is a non-selective AMYR/CTR agonist. Specific EC50 values not publicly available; functional potency is comparable to native amylin at AMYR.
Source:MCE: Cagrilintide (CAS 1415456-99-3); Novo Nordisk REDEFINE program.
Clinical Development:
References-
PubChem:Literature:
MCE: Cagrilintide (CAS 1415456-99-3); ClinicalTrials.gov: REDEFINE-1 (NCT05249895); Novo Nordisk: EASD 2025 Cagrilintide data presentation
Disclaimer:Cagrilintide is NOT FDA-approved or EMA-approved. It is in Phase 3 clinical trials (REDEFINE program). This listing is for industrial and laboratory research use only. It is not medical advice, a clinical recommendation, or an approved therapy description. Always verify regulatory status, purity, and intended use with the supplier and applicable authorities before purchase or use.
-
-
Seller Information
-
Business Type:
Manufactory
-
Main Products:
Peptides,steriods oil,pharmaceutical intermediates,chemical,raw powder,Retatrutide
-
Location:
15b3-1, Building 3, China Plastic City International Business Center, No. 285 Shunda West Road, Yangming Street, Ningbo, Zhejiang, China
-
Payment Terms:
TT against copy of documents,TT against B/L draft before shipment,100% TT in advance
-
Average lead Time:
5
-
Total Annual Revenue:
$5 million-$10 million
-
Total Employees:
11-50
-
Year of Establishment:
2024
-
-
Inquiry History5 Inquiries
Country Product Purchase Quantity Date Posted 
Croatia
CJC 1295 DAC
100 MG Jul 6, 2024 
South Korea
steroid oil
10 L Nov 30, 2023 
Germany
CJ-C-1295 Whitout DAC
10 Mar 2, 2026 
United States
CJC 1295 DAC
100 MG Jul 25, 2025 
United Kingdom
Roids sarm
1 MT Mar 7, 2024 Post an enquiry for this product
- Hot Searches
- where to buy cerebrolysin peptide
- maleic anhydride safety data sheet
- benzalkonium chloride purchase
- pet prices
- petrochemical prices
- where to get retatrutide
- buy 2cb online
- where can i get retatrutide
- polytetramethylene glycol
- calcium sulfate dihydrate
- ammonium nitrate prices
- retatrutide vendor